相关实验视频

Updated: Mar 12, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

在患有左心室功能障碍的患者中,气球与自我膨胀的TAVI相比:现实世界的比较研究

Edward Dababneh^1,2, Maria Gabriela Matta¹, Selvanayagam Niranjan^1,2

¹Department of Cardiology, Gold Coast Health Service, Gold Coast, Queensland, Australia.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

|March 10, 2026

概括

过导管大动脉植入 (TAVI) 改善了严重大动脉狭窄和左心室功能减弱的患者的喷射率,无论门类型如何. 自扩展 (SEV) 提供了血液动力学的好处,但与气球可扩展 (BEV) 相比,它不会改变喷射部分的恢复或临床结果.

科学领域:

心脏病学心脏病学
心血管外科心血管外科
医疗器械医疗器械

背景情况:

严重的大动脉狭窄与左心室射出分数 (LVEF) 的减少影响了缩功能.
过导管大动脉植入 (TAVI) 是这些患者的一种治疗选择.
自扩展 (SEV) 可能比气球扩展 (BEV) 提供血液动力学优势,但它们对LVEF恢复的影响尚不清楚.

研究的目的:

在TAVI患者中比较BEV和SEV之间的射出分数变化,LVEF<40%.
评估TAVI后30天和12个月的血液动力学性能和临床结果.
根据环状周长来调查子组差异.

主要方法:

使用国家注册的观察队列研究.
包括LVEF<40%和特定排除标准的成年人.
最接近邻居匹配用于平衡患者特征;30天和12个月后评估心声和临床结果 (MACCE).

主要成果:

喷射率提高了30天,并在12个月内持续,在BEV和SEV组之间没有显著差异.
在两个时间点 (p < 0.001) 中,SEV 显示出优越的血液动力学与较低的平均梯度.
主要不良心脏和脑血管事件 (MACCE) 在30天和12个月的组之间是相似的,在环大小小组中一致.

结论:

在LVEF降低的患者中,TAVI导致喷射分数持续改善,无论使用的门平台如何.
虽然SEV提供了血液动力学优势,但与BEV相比,它们不会导致喷射分量的差异恢复或改善临床结果.
在这种患者群体中,在BEV和SEV之间的选择似乎不会影响长期功能恢复或临床事件.

关键词:

大动脉狭窄症 (大动脉狭窄症)气球膨胀门可以扩展.左心室喷射分数的部分.自扩展的自扩展.穿过导管的大动脉植入装置.膜心肌病症膜心肌病症

更多相关视频

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Published on: January 20, 2022

相关概念视频

Aortic Regurgitation III: Medical Management

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Mitral Stenosis III: Medical Management

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...